Olaparib 100 mg, 150 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 100 mg, 150 mg
Reference Brands: Lynparza® (US & EU)
Category: Oncology Cancer Care
Olaparib Tablets (brand: Lynparza®) are oral PARP inhibitors for ovarian, breast, pancreatic, and prostate cancers, especially in BRCA-mutated cases. Available in 100 mg and 150 mg, and approved in the US and EU, Olaparib offers a reliable, GMP-compliant oncology solution for global B2B pharmaceutical distribution.
Product Description: Olaparib Tablets, sold under the brand name Lynparza®, are oral PARP inhibitors used in treating advanced ovarian, breast, pancreatic, and prostate cancers, especially in patients with BRCA mutations. Olaparib interferes with cancer cell DNA repair, enhancing cell death in tumors with deficient repair mechanisms. Available in 100 mg and 150 mg strengths, these tablets are approved in both the US and EU and manufactured under GMP-certified facilities. As a breakthrough targeted therapy, Olaparib is a valuable option for oncology-focused pharmaceutical partners seeking high-quality, globally compliant formulations for B2B supply in regulated markets.
Olaparib — third party manufacturing & bulk supply
Olaparib 100 mg, 150 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Olaparib is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Olaparib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Olaparib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
